Leadless Patient Selection: TTVR and Active Infections

  • Published:  09 April 2026
  • Likes: 

    Heart Icon

    0

Up Next

Leadless Patient Selection: TTVR and Active Infections

  • Published:  09 April 2026
  • Likes: 

    Heart Icon

    0

Average (ratings)
No ratings
Your rating
Overview

Discover the future of pacing in complex structural and high-risk patients with insights from some of the world’s leading experts.

 

Prof Aldo Rinaldi (Guy's and St Thomas’ NHS Foundation Trust, UK) and Dr Tiffany Patterson (Guy’s and St Thomas’ NHS Foundation Trust, UK) explore the latest advances in leadless pacemaker technology, with a particular focus on its role in patients undergoing Transcatheter Tricuspid Valve Replacement (TTVR) and other complex structural interventions. The series examines how leadless pacing can overcome the limitations of transvenous leads in patients with tricuspid valve disease, prior valve interventions, venous occlusion and high infection risk.

 

They are joined by Prof Eyal Nof (Sheba Medical Center, IL), who addresses one of the most challenging clinical scenarios faced by interventional teams – pacing strategies in patients with active infection and device extraction. The discussions cover patient selection, procedural planning, device implantation techniques and strategies to minimise complications in high-risk populations.

 

Through real-world case discussions and interactive Q&A, the series provides practical insight into how leadless pacing integrates into structural heart and complex intervention workflows, including peri-procedural considerations, imaging guidance, complication management and post-implant follow-up.

This video series is supported by

Learning Objectives

  • Identify the key indications and procedural advantages of leadless pacemakers in patients undergoing TTVR and other structural heart interventions
  • Understand the role of leadless pacing in patients with active infection, device extraction or limited venous access
  • Apply case-based procedural strategies for patient selection, implantation planning and complication management when using leadless pacing in complex patients

Target Audience

  • Interventional Cardiologists
  • Electrophysiologists
  • General Cardiologists
  • Other healthcare professionals involved in structural heart disease, device therapy and leadless pacing pathways

More from this programme

Part 1

Welcome and Introduction

Dr Alphons Vincent opens the webinar, shares the educational goals and provides an introduction to the topic.

Part 2

Leadless Pacemakers in Transcatheter Tricuspid Valve Repair Patients

Dr Tiffany Patterson and Prof Aldo Rinaldi review the latest evidence on cardiac implantable electronic devices (CIEDs) in the setting of transcatheter tricuspid valve repair, highlighting the advantages and considerations of leadless pacemakers.


 

Part 3

Leadless Pacemakers in Patients With Active CIED Infection

Dr Eyal Nof explores the use of leadless pacemakers in patients with active CIED infections, focusing on their clinical role, real-world experience and cost considerations.

Part 4

Questions and Answers

The faculty answer audience questions, share expert insights and participate in an interactive discussion.

Faculty Biographies

Tiffany Patterson

Tiffany Patterson

Consultant Cardiologist

Dr Tiffany Patterson is a Consultant Cardiologist and Senior Lecturer at Guys and St Thomas’ NHS Foundation Trust, London, UK.

Dr Patterson specialises in transcatheter mitral and tricuspid edge to edge repair and replacement, high-risk PCI and complex TAVI.

View full profile
Aldo Rinaldi

Aldo Rinaldi

Prof Christopher Aldo Rinaldi is a consultant at Guy’s and St Thomas’ NHS Foundation Trust, London, UK 

Prof Rinaldi was trained in medicine at King’s College Hospital, becoming a member of the Royal College of Physicians in 1993 and subsequently a fellow in 2006. He trained in cardiology at Guy’s and St Thomas’ with dual accreditation in cardiology and general medicine.

Prof Rinaldi obtained his MD in 2001 and undertook his research at the University Hospital of Wales and Hammersmith Hospital. He became a fellow of the Heart Rhythm Society in 2013. In 2014 he was promoted to professor of cardiac electrophysiology and devices at King’s College London, where he leads the Cardiac Device Research Programme.

View full profile
Eyal Nof

Eyal Nof

Director of Invasive Electrophysiology Service

Dr Eyal Nof is the Director of Invasive Electrophysiology Service at Sheba Medical Center, Ramat Gan, IL.

Dr Nof now primarily focuses on complex ablations, particularly VT ablations and lead extractions.

View full profile
Alphons Vincent

Alphons Vincent

Alphons Vincent is Medical Director for the Cardiac Rhythm Management division of Medtronic in Western Europe. During his 33-year tenure at Medtronic, he has held various roles across marketing, business, clinicals, education, and medical affairs. His extensive experience spans work with Vitatron, a pacemaker company within the Medtronic corporation, as well as Cardiac Surgery (heart valves), Subcutaneous Diagnostics and Monitoring (Reveal), and Cardiac Rhythm Management.

Dr Vincent holds a medical degree from the Medical School at the University of Nijmegen, The Netherlands, complemented by bachelor’s degrees in Management Information Systems and Economics from the University of Tilburg, The Netherlands.

In his current role, he is responsible for physician advisory boards, scientific and educational symposia, clinical evidence strategy, the Office of Medical Affairs, and professional relations with medical societies and associations. He also plays a key coordinating…

View full profile